首页> 美国卫生研究院文献>Schizophrenia Bulletin >SU129. Transcultural Comparison of the Impact of Symptomatic Remission and Resilience on Health-Related Quality of Life in Patients Suffering From Serious Mental Illness
【2h】

SU129. Transcultural Comparison of the Impact of Symptomatic Remission and Resilience on Health-Related Quality of Life in Patients Suffering From Serious Mental Illness

机译:SU129。症状缓解和适应力对严重精神疾病患者健康相关生活质量影响的跨文化比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Health-related quality of life (HRQOL) refers to physical, social, well-being, and functional domains and is an increasingly important outcome measure of serious mental illness (SMI). >Methods: Focusing on transcultural differences, the current study used the WHOQOL-BREF to (1) compare HRQOL of clinically stable patients suffering from schizophrenia (N = 112) or bipolar I disorder (BD-I) (N = 120) with healthy control subjects (N = 137) from Western (Austria) and Eastern cultures (Japan) and (2) investigate whether symptomatic remission and resilience are relevant in this context. >Results: We detected a significant country effect with markedly lower HRQOL among Japanese subjects in general and a significantly higher degree of resilience in Austrian schizophrenia patients and healthy control subjects. Both Austrian patient groups and the Japanese schizophrenia group indicated significantly lower HRQOL and resilience compared to healthy control subjects. On the contrary, Japanese patients suffering from BD-I were comparable with control subjects in this regard. In both countries, nonremitted patients indicated significantly lower HRQOL than those who were symptomatically remitted. However, being free of mental illness/symptomatically remitted did not account for the observed cross-cultural and between-group differences in HRQOL. In addition, resilience was found to be a highly significant predictor of HRQOL in both countries and in all 3 groups and to be largely responsible for between-group differences in HRQOL. >Conclusion: Our findings demonstrate that even during periods of clinical stability HRQOL is significantly affected in individuals suffering from SMI and that individuals from Western European and Japanese cultures may have different needs in this regard. It remains to be studied whether interventions targeting the improvement of resilience might have a positive impact on patients’ HRQOL and whether the effects of such training programs might differ between diagnostic groups, remittedonremitted patients, and across cultures.
机译:>背景:与健康相关的生活质量(HRQOL)指的是身体,社会,幸福和功能领域,是严重精神疾病(SMI)日益重要的结果指标。 >方法:当前研究集中在跨文化差异上,使用WHOQOL-BREF来(1)比较患有精神分裂症(N = 112)或双相I型障碍(BD-I)的临床稳定患者的HRQOL( N = 120)来自西方(奥地利)和东方文化(日本)的健康对照受试者(N = 137),并且(2)研究在这种情况下症状缓解和适应力是否相关。 >结果:我们在日本人群中发现了显着的国家效应,HRQOL显着降低,奥地利精神分裂症患者和健康对照者的抗逆力明显升高。奥地利患者组和日本精神分裂症组均显示与健康对照组相比,HRQOL和适应力明显降低。相反,在这一点上,患有BD-I的日本患者与对照组相当。在这两个国家中,未缓解患者的HRQOL显着低于那些有症状缓解的患者。但是,没有精神疾病/症状缓解并不能解释HRQOL中观察到的跨文化差异和群体间差异。此外,在两个国家和所有三个组中,恢复力都是HRQOL的高度重要预测指标,并且是HRQOL组间差异的主要原因。 >结论:我们的发现表明,即使在临床稳定的时期,HRQOL也会严重影响SMI患者,并且西欧和日本文化的患者在这方面可能有不同的需求。有针对性的干预措施是否会改善患者的HRQOL,以及这些培训计划的效果在诊断组之间,可否/未允许患者之间以及在不同文化间是否可能存在差异,还有待研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号